| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.052 | 0.3 |